Hematopathology (Lecture II)
Hematopathology (Lecture II)
Hematopathology (Lecture II)
lecture part II
- diseases of red blood cells
color:
• normochromic
• hypochromic
• hyperchromic
• anisochromic – unequal color
• polychromatic – bazophilic color
Erythrocytes morfology variations
shape:
normal – round, biconcave (discoid)
signs:
• ↓ oxygen transport to tissues → fatigue, dyspnea, angina pectoris, organ
failure
• ↓ plasma volume → pallor, postural hypotension
• ↑ cardiac output → palpitation, heart murmurs, tachycardia
→ anemic syndrome
Anemia
classification:
1) morphological: according the shape and color of erythrocytes
2) patophysiological:
• erytropoiesis defect
– DNA synthesis defect
– hemoglobin synthesis defect
– erythropoietin insufficiency
– hemopoietic stem cell deficiency
• increased loss of erythrocytes
– posthaemorrhagic
– hemolytic
Video - Anemia of decreased red cell production
Video - anemia of increased red cell destruction (loss)
Forms of anemia
Prevalence of anemia
Megaloblastic anemia
(DNA synthesis disorder)
• insuficiency of folic acid (vitamin B9) and cobalamin (vitamin B12)
→ failure of DNA synthesis and cell cycle slowdown →
megaloblasts formation (huge erythrocytes with immatured
nucleus) → shortened lifespan → anemia
Megaloblastic anemia
(DNA synthesis disorder)
• folic acid – transport of one-carbon residues – thymin synthesis:
– N5, N10 – methylenetetrahydrofolate → deoxythymidylate
• cobalamin – transfer of homocysteine to methionine +
regeneration of tetrahydrofolate from methyl-tetrahydrofolate
Megaloblastic anemia
- etiology
folic acid insufficiency:
• inadequate dietary intake (elderly people, alcoholism)
• malabsorption (gluten enteropathy, bowel inflammation)
• increased consumption (pregnancy)
• increased loss (dialysis)
• drugs (cholestyramine, methotrexate, fluorouracil, trimethoprim)
Megaloblastic anemia
- etiology
cobalamin insufficiency (pernicious anemia):
• inadequate dietary intake (strict vegetarian diet)
• intrinsic factor insufficiency (atrophic gastritis, post resection state, antibodies)
• malabsorption (resection and inflammation of terminal ileum)
• defect of transcobalamin II
Megaloblastic anemia
- pernicious anemia
clinical features – specific signs:
• pale skin (yellowish tint)
• glossitis (swollen tongue)
• decreased homocysteine degradation →
hyperhomocysteinemia – risk factor of atherosclerosis,
trombosis and ischemic heart disease
• lack of methionine (for choline and phospholipids formation)
→ demyelination of nerve fibers, axon degeneration,
neuronal cell death → dementia, psychosis
Anemia due to hemoglobin
synthesis disorder
classification:
• disorder of protoporphyrin synthesis – porphyria →
sideroblastic anemia
• disorder of heme synthesis due to lack of iron → sideropenic
anemia
• disorder of globin synthesis – sickle cell anemia, thalassemia
Porphyria
• usually inherited (mostly autosomal dominant) disorder of
heme synthesis – defects of enzymes needed at various steps
→ lack of heme
→ accumulation and increased excretion of porphyrins and
their precursors
– early steps – neurotoxicity of early precursors (aminolevulinic acid and
porphobilinogen) → periodic acute attacks of neurovisceral symptoms:
abdominal pain, neurologic deficits, psychiatric symptoms and red urine
– final steps – accumulation of protoporphyrins in skin → photosensitivity
Porphyria
Sideropenic anemia
- lack of iron
• most common type of anemia
• easily treated disorder with an excellent outcome
Etiology:
• increased loss of iron (bleeding, blood donation)
• insufficient dietary intake
• malabsorption (achlorhydria, inflammation, iron chelators)
• disrupted recycling (chronic infections)
• increased demand (pregnancy, growth period)
Sideropenic anemia
- etiology
Sideropenic anemia
- etiology
Sideropenic anemia
- etiology
Sideropenic anemia
- clinical features
• mikrocytic hypochromic anemia
• pallor of skin and mucous
membranes
• abnormalities of epithelial
tissues:
– esophageal webbing
– koilonychia
– glossitis
– angular stomatitis
– gastric atrophy
Sideropenic anemia
- clinical features
chipmunk facies
Glucose-6-phosphate
dehydrogenase (G6PD) deficiency
• G6PD enzyme is part of the pentose monophosphate shunt – only
source for NADPH in erythrocytes (maintaining glutathione in its
reduced form – scavenger for dangerous oxidative metabolites) →
in persons with G6PD deficiency, oxidative stresses can denature
hemoglobin and cause intravascular hemolysis
Glucose-6-phosphate
dehydrogenase (G6PD) deficiency
• most common enzyme deficiency in humans (400 million people)
• high prevalence in persons of African, Asian and Mediterranean
descent
• X-linked recessive disorder
(males usually manifest the abnormality and females are carriers)
• degree of G6PD deficiency determines the clinical expression:
– minimally reduced enzyme levels → asymptomatic
– greater degree of deficiency → episodes of brisk hemolysis triggered by
infections or oxidative stress (self-limiting within 8 to 14 days)
– severe deficiency → chronic hemolysis